A5021309574- Acute Ischemic Stroke Management
- Medical and Biological Sciences
- Cerebrovascular and Carotid Artery Diseases
- Neurological Disorders and Treatments
- Cerebral Venous Sinus Thrombosis
- Blood Pressure and Hypertension Studies
- Botulinum Toxin and Related Neurological Disorders
- S100 Proteins and Annexins
- Stroke Rehabilitation and Recovery
- Healthcare Systems and Public Health
Irkutsk Regional Clinical Hospital
2020-2025
Thrombolytic therapy (TLT) of ischemic stroke (IS) with alteplase within the first 4.5 hours from onset symptoms is most effective and proven method treatment. Objective: to evaluate safety efficacy TLT Revelisa (alteplase) in IS real-world clinical practice. Material methods. The results were analyzed 1181 patients IS: 616 (52.2%) women 565 (47.8%) men (mean age 68.28±12.56 years), which 140 (11.9%) staged reperfusion. mean time disease was 2.58±0.83 hours. Heidelberg classification used...
A case report of successful intravascular aspiration in a patient with acute cardioembolic stroke is presented. Non-occlusive critical thrombosis the extracranial segment left internal carotid artery distal total embolization medial cerebral was verified. During intervention, dislocation thrombotic masses into supraclinoid occurred.